Statistical work on biotechnology is carried out under the aegis of the OECD Working Party of National Experts on Science and Technology Indicators (NESTI). The above document gives the outcome of the 2004 experts' meeting.
How precisely does ICT affect economic growth and the efficiency of firms? How well can these impacts be measured? And under which conditions do the impacts of ICT emerge?
The S&T Statistical Compendium 2004 looks at the state of science and technology in the OECD across four broad dimensions: innovation and R&D; human resources in science and technology (HRST); patents; and other areas (ICT, globalisation, industrial structure).
English, , 260kb
This document provides a framework for the national certification (independent review by third party) of biological resource centres as defined by the OECD. Compliance with this guidance is mandatory for those bodies that are part of a Global Biological Resource Centre Network.
English, , 327kb
The OECD should strengthen its contribution to work on biotechnology as a driver for sustainable growth, focusing on the issues identified and conclusions reached in this paper.
English, , 365kb
This guidance provides the basis for best practice in the management of biological resource centres and all laboratories maintaining replicable biological materials.
This report addresses issues related to governance of public research, describes the challenges and provides evidence of the reforms that have been developed. Good practices are highlighted and policy lessons are drawn.
This publication contains survey data on academic patenting and licensing and several case studies on the policies and practices for managing intellectual property.
This booklet describes how biotechnology and genomics science can be used to fight neglected infectious diseases as well as reviewing the challenges facing Governments to overcome market failure in supply of products. It draws on discussions a...
English, , 669kb
This report presents the findings of an OECD Workshop held in Berlin to establish the impact of patents and licensing on development and access to genetic technology. Few topics in the life sciences today provoke as much debate as the availability of patent protection on "genetic inventions".